Nataliya Mar MD

picture of Nataliya  Mar

Associate Clinical Professor, Division of Hematology/Oncology, Medicine
School of Medicine


M.D., SUNY Downstate School of Medicine, 2009, Medicine
B.A., New York University, College of Arts and Science, 2004, Biochemistry

Phone: (714) 456-8000
Fax: (714) 456-2242
Email: marn@hs.uci.edu

University of California, Irvine
101 The City Drive South
Mail Code: 4061
Orange, CA 92868
Research Interests
Genitourinary cancer, prostate cancer, bladder cancer, kidney cancer
Research Abstract
Dr. Nataliya Mar is an associate professor at UC Irvine Chao Comprehensive Cancer Center, who specializes in treatment of genitourinary malignancies including prostate, bladder, kidney, testicular and penile cancers. She is a principal investigator or a co-investigator on many clinical trials evaluating new therapies in genitourinary cancers. She has authored multiple peer-reviewed publications and presented her research at various national oncology meetings.
Awards and Honors
2022 Physician of Excellence selected by the Orange County Medical Association
2021 Physician of Excellence selected by the Orange County Medical Association
2020 Top 20 physicians with a highest patient satisfaction score at UC Irvine
2018 Top 20 physicians with a highest patient satisfaction score at UC Irvine
Publications
Shields LBE, Alsorogi MS, Mar N, Rezazadeh A. Immune-Related Meningoencephalitis Following Nivolumab in Metastatic Renal Cell Carcinoma. Case Rep Oncol. 2021 Jul 1;14(2):1051-1058.
 
Dobry A, Virgen CA, Hosking AM, Mar N, Doan L, Lee B, Smith J. Cutaneous reactions with enfortumab vedotin: a case series and review of the literature. JAAD Case Rep. 2021 Jun 4;14:7-9.
 
Mar N, Rezazadeh A. Adjuvant pembrolizumab in high-risk patients with muscle-invasive bladder cancer post neoadjuvant chemotherapy and radical cystectomy. J Oncol Pharm Practice. 2021 May 20;10781552211016526.
 
Rezazadeh Kalebasty A, Houshyar R, Mar N. Metastatic clinically-aggressive non-invasive low-grade urothelial carcinoma arising post autologous transplant – case report and review of the literature. J Case Rep Med. 2021 Mar;10,1,33-36.
 
Shields L, Daniels M, Mar N, Rezazadeh Kalebasty A. Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy. World J Clin Oncol. 2021 Mar 24;12(3):183-194.
 
Mar N, Rezazadeh A, Uchio E. Management of advanced prostate cancer in clinical practice - real world answers to challenging dilemmas. J Oncol Pract. 2020 Dec;16(12):783-789.
 
Eisenbud L, Ejadi S, Mar N. Development of Carpal Tunnel Syndrome in Association with Checkpoint Inhibitors. J Oncol Pharm Pract. 2021 Apr;27(3):764-765.
 
Baweja A, Mar N. Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab. J Oncol Pharm Pract. 2021 Jan;27(1):212-215.
 
Mar N, Dayyani F. Management of urothelial bladder cancer in clinical practice – real world answers to difficult questions. J Oncol Pract. 2019 Aug;15(8):421-428.
 
Mar N, Pan C, Houshyar R. Aberrant collateral vascular network within the heart as a consequence of metastatic renal cell carcinoma. Journal of Clinical Urology. First published online on December 20, 2018.
 
Mar N, Houshyar R, Jordan M. Use of Neoadjuvant Sunitinib in Renal Cell Carcinoma of a Transplanted Kidney. J Oncol Pract. 2018 Aug 22:JOP1800292.
 
Mar N, Digiuseppe J, Dailey M. Rubinstein-Taybi syndrome – a window into follicular lymphoma biology. Leuk Lymphoma. 2016 Apr 18:1-3.
 
Mar N, Vredenburgh JJ. Dual HER2 blockade in non-small cell lung cancer harboring a HER2 mutation. Conn Med. 2015 Oct;79(9):531-5.
 
Mar N, Desjardins A, Vredenburgh JJ. CCR 20th Anniversary Commentary: Bevacizumab in the Treatment of Glioblastoma - The Progress and the Limitations. Clin Cancer Res. 2015 Oct 1;21(19):4248-50.
 
Mar N, Vredenburgh JJ, Wasser JS. Targeting HER2 in the treatment of non small cell lung cancer. Lung Cancer. 2015 Mar;87(3):220-5.
 
Mar N, Kosowicz R, Hook K. Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss. J Thromb Thrombolysis. 2014 Aug;38(2):196-200.
 
Mar N, Gorgan MA, Dailey ME, Vredenburgh JJ. Blue toes and a new pair of shoes - challenges in diagnosis and treatment of acute myelogenous leukemia. Am J Hematol. 2013 Dec;88(12):1090-3.
 
Mar N, Askin D, George J, Spaccavento C, Graham G, Ratner L. Challenges in managing a patient with multiple primaries. Community Oncology. 2012 Dec;9(12):377-381.
 
Mar N, Askin D, Klafter R. Pitfalls in the diagnosis of vitamin B12 deficiency. Open Journal of Hematology. 2012 Sep;3(1):2.
 
Mar N, Graham RE. A lung abscess, esophageal dilatation and bulimia - six degrees of separation from adjustable gastric banding. Surg Obes Relat Dis. 2012 Mar-Apr;8(2):e11-3.
Professional Societies
American Society of Clinical Oncology (ASCO)
Medical Oncology Association of Southern California (MOASC)
American Society of Hematology (ASH)
American College of Physicians (ACP)
Other Experience
Internal Medicine Internship and Residency
Lenox Hill Hospital, New York, NY 2009—2012

Hematology/Oncology Fellowship
University of Connecticut, Farmington, CT 2012—2015

Research Center
Chao Family Comprehensive Cancer Center
Last updated
10/14/2021